VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
48 hedge funds and large institutions have $33M invested in Viracta Therapeutics, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
4% less funds holding
Funds holding: 50 → 48 (-2)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
Holders
48
Holding in Top 10
1
Calls
$511K
Puts
$542K
Top Buyers
| 1 | +$2M | |
| 2 | +$125K | |
| 3 | +$119K | |
| 4 |
KAM
Kazazian Asset Management
Fort Lauderdale,
Florida
|
+$70K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$32K |
Top Sellers
| 1 | -$467K | |
| 2 | -$94K | |
| 3 | -$80.9K | |
| 4 |
TI
Telemetry Investments
New York
|
-$80.5K |
| 5 |
Two Sigma Investments
New York
|
-$65.6K |